GSTM1 and depressive symptom measurement: Although, thus far, there have been no reports of clear evidence of the effects of medication on NIRS signals, a recent longitudinal NIRS study reported no differences in VFT-induced oxy-Hb changes between pre- and post-antidepressant treatment time points in a MDD cohort, despite significant improvements in symptoms of depression [22].